Levonorgestrel-Releasing Intrauterine System With or Without Everolimus in Treating Patients With Atypical Hyperplasia or Stage IA Grade 1 Endometrial Cancer

NCT02397083 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

102

Enrollment

OTHER

Sponsor class

Conditions

Atypical Endometrial Hyperplasia
FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma
FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma

Interventions

DRUG: Everolimus
OTHER: Laboratory Biomarker Analysis
DEVICE: Levonorgestrel-Releasing Intrauterine System

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]